cancer therapeutics

    cancer therapeutics Market Research Reports

    Titlepublishedprice

    EpiCast Report: Breast Cancer (HER2-, HER2+) – Epidemiology Forecast to 2023

    By GlobalData
    "......s and exogenous sex hormones, gene mutations, a family history of breast cancer, overweight and obesity, physical inactivity, a sedentary lifestyle, high alcohol consumption, early age at menarche (<12 years), late age at menopause (>55 years),......"
    10-Sep-2014$3995

    Uterine Cancer – Pipeline Review, H2 2014

    By Global Markets Direct
    "......th comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key player......"
    10-Sep-2014$2000

    Global Non-small Cell Lung Cancer Market 2014-2018

    By Infiniti Research Limited
    "......rbidity not only in developed countries but also in developing countries. One of the most common types of lung cancer is non-small cell lung cancer. It grows and spreads quite slowly. Smoking is considered as a major cause of lung cancer, although lu......"
    10-Sep-2014$2500

    Burkitt Lymphoma – Pipeline Review, H2 2014

    By Global Markets Direct
    "......plete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews ke......"
    10-Sep-2014$2000

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) – Pipeline Review, H2 2014

    By Global Markets Direct
    "...... development for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type,......"
    31-Aug-2014$2000

    Cervical Cancer – Pipeline Review, H2 2014

    By Global Markets Direct
    "......eutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cer......"
    31-Aug-2014$2000

    OpportunityAnalyzer: Non-Hodgkin’s B-Cell Lymphoma – Opportunity Analysis and Forecast to 2018

    By GlobalData
    "...... the four largest B-cell NHL indications, which includes Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Marginal Zone Lymphoma (MZL), and Mantle Cell Lymphoma (MCL), currently revolves around multiple rounds of Rituxan-based chemoth......"
    25-Aug-2014$7995

    EpiCast Report: Renal Cell Carcinoma – Epidemiology Forecast to 2023

    By GlobalData
    "......urine. The condition is asymptomatic in its initial stages, and as a result, people with RCC are often in the advanced stages of the disease by the time it is discovered. The initial symptoms of RCC often include blood in the urine, flank pain, a mas......"
    25-Aug-2014$3995

    Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 – Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM

    By GBI Research
    "......oblastoma Multiforme (GBM) therapeutics market within the Asia-Pacific (APAC) region, covering Australia, China, India and Japan. The report provides estimates of market size for 2013, along with market forecasts until 2020. It also covers disease ep......"
    20-Aug-2014$4995

    Global Hodgkins Lymphoma Therapeutics Market 2014-2018

    By Infiniti Research Limited
    "......ymphatic system grow unusually and may spread beyond the lymphatic system. The infection-fighting properties of the lymphocytes are lost, making the person more susceptible to infection. The main treatments used are chemotherapy, followed by radiothe......"
    6-Aug-2014$2500
    Live Chat
    Live Chat by Comm100